Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AmpliPhi Recieves Positive FDA Feedback for its Bacteriophage Candidate AB-PA01 Development Plans Targeting Pseudomonas Aeruginosa Infections
AmpliPhi Recieves Positive FDA Feedback for its Bacteriophage Candidate AB-PA01 Development Plans Targeting Pseudomonas Aeruginosa Infections
AmpliPhi Recieves Positive FDA Feedback for its Bacteriophage Candidate AB-PA01 Development Plans Targeting Pseudomonas Aeruginosa Infections
Submitted by
admin
on September 18, 2018 - 9:52am
Source:
CP Wire
News Tags:
Ampliphi Biosciences
AB-PA01
bacteriophage
Headline:
AmpliPhi Recieves Positive FDA Feedback for its Bacteriophage Candidate AB-PA01 Development Plans Targeting Pseudomonas Aeruginosa Infections
snippet:
Company received positive written response from FDA regarding development plans
Resistant
P. aeruginosa
is designated as ‘Priority 1: Critical’ pathogen by the World Health Organization
Do Not Allow Advertisers to Use My Personal information
